Endometrial cancer risk is rising, especially among premenopausal women, with diet and lifestyle factors playing a central ...

Unlike cervical cancer, endometrial cancer often presents with symptoms at an early stage, per the Mayo Clinic, resulting in ...

Endometrial cancer usually returns within three years after treatment. Most of the studies that looked at recurrence rates lasted less than five years, so it's hard to know exactly how many ...

GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

The treatment combines pembrolizumab, made by Merck Sharp & Dohme, with chemotherapy drugs carboplatin and paclitaxel. Pembrolizumab is an immunotherapy that helps the immune system recognise and ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...

Women with advanced form womb cancer have been given fresh hope after a new treatment was given the green light for ...

Understanding Obesity and Endometrial Cancer Risk: Opportunities for Prevention Schmandt RE, Iglesias DA, Co NN, Lu KH Am J Obstet Gynecol. 2011;205:518-525 ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

GlaxoSmithKline Pharmaceuticals said it is bringing in Jemperli and Zejula to India, marking its re-entry into the cancer ...

GlaxoSmithKline (GSK) on Monday announced its foray into the Indian oncology market with the launch of two precision ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...